dr mark hyman glutathione The Revolution: Fight Disease, Slow Aging, and Increase Energy with the Master Antioxidant Dr. Hyman & Dr. Lyon

475,476 In the phase 3 GeparQuinto trial, bevacizumab was added to patients treated with anthracycline and taxane, which significantly improved the pCR rate in BRCA1 /2 mutation carriers

C.EndoA.HillC.LebeerS.QuigleyE

doi: 10.21037/atm-21-4958

It provides an effective solution to reduce dark spots, hyperpigmentation, and blemishes by bringing the benefits of glutathione and kojic acid together

The peptide exhibits high-affinity copper binding (Kd ~10 M), creating a stable complex that delivers copper to cells while protecting against copper-induced oxidative damage

Shores adds more products to his wellness repertoire